Korean J Obstet Gynecol Search


Korean Journal of Obstetrics & Gynecology 1999;42(10):2264-2269.
Published online January 1, 2001.
Expression of p53 and MDM-2 Protein in Cervical Neoplasia.
Chan Woo Chung, Yong Kag Shin, Chae Woong Park, Chang Joo Kim, Tae Il Cho, Eon Sub Park
MDM-2 is an oncoprotein that inhibits p53 tumor suppressor protein. Amplication and over- expression of its protein have been observed in human malignancies, and these abnormalities have a role in tumorigenesis through inactivation of p53 function. To elucidate the role of p53 and MDM-2 protein in cervical neoplasia we investigated the expression rates of MDM-2 and p53 protein in surgically resected specimens. METHEDS: Immunohistochemical studies using anti-p53 and anti-MDM-2 protein in the paraffin embedded section of 62 cases including cervical intraepithelial neoplasm(CIN) and invasive cervical cancer were performed. RESULTS: Expression rates of p53 protein were 25% in CIN I& CINII, 20% in CINIII, and 44% in invasive carcinoma, respectively. The MDM-2 protein were 33% in CIN I & CIN II, 16% in CIN III, and 48% in invasive carcinoma, respectively. There was no evident correlation between p53 positivity and MDM-2 positivity(p>0.05). However, correlation between MDM-2 negativity and p53 negativity was statistically significant(p=0.002) CONCLUSION: These data suggest that the expression of p53 protein is presumed to be necessarily correlated with MDM-2 protein expression in cervical neoplasia.
Key Words: Cervical neoplasia, p53 protein, MDM-2 protein, p53, MDM-2

Article category

Browse all articles >


Browse all articles >

Editorial Office
49-2 Chungmu-ro, Jung-gu, Seoul 04550, Korea
Tel: +82-2-2266-7238    Fax: +82-2-2277-5194    E-mail: journal@ogscience.org                

Copyright © 2023 by Korean Society of Obstetrics and Gynecology.

Developed in M2PI

Close layer
prev next